AR064895A2 - Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina - Google Patents
Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histaminaInfo
- Publication number
- AR064895A2 AR064895A2 ARP080100161A ARP080100161A AR064895A2 AR 064895 A2 AR064895 A2 AR 064895A2 AR P080100161 A ARP080100161 A AR P080100161A AR P080100161 A ARP080100161 A AR P080100161A AR 064895 A2 AR064895 A2 AR 064895A2
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- treatment
- anhidra
- induced disorders
- histamine induced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Abstract
Una composicion farmacéutica anhidra para el tratamiento de desordenes inducidos por histamina, que comprende una cantidad terapéuticamente efectiva de descarboetoxiloratadina, o una sal farmacéuticamente aceptable de la misma y un portador farmacéuticamente aceptable. Reivindicacion 5: La composicion farmacéutica de la reivindicacion 4, caracterizada porque el analgésico es ácido acetilsalicílico, acetaminofén, ibuprofeno, ketofén, naproxeno o una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3732597P | 1997-02-07 | 1997-02-07 | |
US4518497P | 1997-04-30 | 1997-04-30 | |
US5305097P | 1997-07-21 | 1997-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064895A2 true AR064895A2 (es) | 2009-05-06 |
Family
ID=27365195
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100521A AR011114A1 (es) | 1997-02-07 | 1998-02-05 | COMPOSICIoN FARMACÉUTICA LIBRE DE LACTOSA EN FORMA GRANULADA O EN MEZCLA PARA EL TRATAMIENTO DE DESoRDENES INDUCIDOS POR HISTAMINA. |
ARP080100161A AR064895A2 (es) | 1997-02-07 | 2008-01-14 | Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina |
ARP080100162A AR064896A2 (es) | 1997-02-07 | 2008-01-14 | Composicion farmaceutica no higroscopica |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100521A AR011114A1 (es) | 1997-02-07 | 1998-02-05 | COMPOSICIoN FARMACÉUTICA LIBRE DE LACTOSA EN FORMA GRANULADA O EN MEZCLA PARA EL TRATAMIENTO DE DESoRDENES INDUCIDOS POR HISTAMINA. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080100162A AR064896A2 (es) | 1997-02-07 | 2008-01-14 | Composicion farmaceutica no higroscopica |
Country Status (29)
Country | Link |
---|---|
US (2) | US20020123504A1 (es) |
EP (2) | EP0969836B1 (es) |
JP (1) | JP2001511184A (es) |
KR (5) | KR20060132053A (es) |
CN (1) | CN1132579C (es) |
AR (3) | AR011114A1 (es) |
AT (1) | ATE345133T1 (es) |
AU (1) | AU6271998A (es) |
BR (1) | BR9806157A (es) |
CA (1) | CA2267136C (es) |
CO (1) | CO4940445A1 (es) |
CZ (1) | CZ119499A3 (es) |
DE (1) | DE69836424T2 (es) |
DK (1) | DK0969836T3 (es) |
ES (1) | ES2271986T3 (es) |
HK (1) | HK1024187A1 (es) |
HU (1) | HUP0001527A3 (es) |
MY (1) | MY136999A (es) |
NO (2) | NO325611B1 (es) |
NZ (1) | NZ335041A (es) |
PE (1) | PE71699A1 (es) |
PL (1) | PL192075B1 (es) |
PT (1) | PT969836E (es) |
RU (1) | RU2209627C2 (es) |
SK (1) | SK286035B6 (es) |
TW (1) | TW522014B (es) |
UA (1) | UA70290C2 (es) |
WO (1) | WO1998034614A1 (es) |
ZA (1) | ZA98977B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69940932D1 (de) * | 1998-07-10 | 2009-07-09 | Schering Corp | Orale Zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5H-benzoÄ5,6Ü-cyclo-heptaÄ1,2-bÜpyridin |
US6100274A (en) * | 1999-07-07 | 2000-08-08 | Schering Corporation | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
AU7589700A (en) * | 1999-09-22 | 2001-04-24 | Schering Corporation | Treating allergic and inflammatory conditions |
US6114346A (en) | 1999-10-22 | 2000-09-05 | Schering Corporation | Treating sleep disorders using desloratadine |
MY125516A (en) | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
WO2001045668A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
AU2276801A (en) | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
KR101199654B1 (ko) * | 1999-12-20 | 2012-11-08 | 머크 샤프 앤드 돔 코포레이션 | 안정한 서방출형의 경구 투여용 조성물 |
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
EP1507774A1 (en) * | 2003-03-12 | 2005-02-23 | Biogal Gyogyszergyar Rt. | Processes for preparation of polymorphic forms of desloratadine |
US20060135547A1 (en) * | 2003-03-12 | 2006-06-22 | Toth Zoltan G | Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
EP1696881A2 (en) * | 2003-12-23 | 2006-09-06 | Sun Pharmaceutical Industries Limited | Stable oral composition |
TWI354569B (en) | 2004-05-28 | 2011-12-21 | Bristol Myers Squibb Co | Coated tablet formulation and method |
BRPI0513417A (pt) * | 2004-07-16 | 2008-05-06 | Cipla Ltd | composição farmacêutica estável, usos de um poliol, e de uma composição, processo para preparar uma composição farmacêutica, e, método para tratar uma condição responsiva à administração de uma anti-histamina |
US20100129310A1 (en) * | 2004-08-09 | 2010-05-27 | Pavak Rajnikanth Mehta | Stabilized desloratadine composition |
US20070004671A1 (en) * | 2005-05-20 | 2007-01-04 | Agarwal Sudeep K | Stable desloratadine compositions |
CA2547274A1 (en) * | 2005-05-20 | 2006-11-20 | Dr. Reddy's Laboratories Limited | Stable desloratadine compositions |
US20070014855A1 (en) * | 2005-07-12 | 2007-01-18 | Rahul Gawande S | Stable desloratadine compositions |
US20080118555A1 (en) * | 2005-10-20 | 2008-05-22 | Glenmark Pharmaceuticals Limited | Stable pharmaceutical composition containing desloratadine |
CA2541045A1 (en) * | 2006-03-24 | 2007-09-24 | Pharmascience Inc. | A descarbonylethoxyloratadine containing pharmaceutical composition |
EP1862462A1 (en) * | 2006-04-10 | 2007-12-05 | Ranbaxy Laboratories Limited | Process for the preparation of desloratadine |
RU2008151047A (ru) * | 2006-06-07 | 2010-07-20 | Сандоз АГ (CH) | Стабильные и биодоступные композиции и новая форма деслоратадина |
ECSP077628A (es) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
TR200806298A2 (tr) | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Farmasötik formülasyon |
EP2398468B1 (en) | 2009-02-17 | 2016-11-30 | KRKA, D.D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
ATE525064T1 (de) | 2009-07-01 | 2011-10-15 | Tiefenbacher Alfred E Gmbh & Co Kg | Pharmazeutische zusammensetzung mit desloratadin |
ES2709487T3 (es) | 2010-05-10 | 2019-04-16 | Lesvi Laboratorios Sl | Formulaciones farmacéuticas estables que contienen un antihistamínico |
TR201009396A2 (tr) | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Desloratadin granüller |
CN102813640B (zh) * | 2012-09-06 | 2016-12-21 | 无锡万全医药技术有限公司 | 一种含地氯雷他定的软胶囊及其制备方法 |
US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
US11938117B2 (en) | 2016-09-01 | 2024-03-26 | Nutrition21, LLC | Magnesium biotinate compositions and methods of use |
CN113230235B (zh) * | 2021-04-15 | 2022-11-11 | 海南普利制药股份有限公司 | 含地氯雷他定的复方缓释胶囊及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
WO1985003707A1 (en) * | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
AU665341B2 (en) * | 1990-12-18 | 1996-01-04 | Wellcome Foundation Limited, The | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
RU2068689C1 (ru) * | 1992-09-24 | 1996-11-10 | Товарищество с ограниченной ответственностью "Лекрон" | Способ получения таблеток парацетамола |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
DE4442999A1 (de) * | 1994-12-02 | 1996-06-05 | Hexal Pharma Gmbh | Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten |
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
US5939426A (en) * | 1997-02-28 | 1999-08-17 | Sepracor Inc. | Methods for treating urinary incontinence using descarboethoxyloratadine |
US6162829A (en) * | 1997-10-17 | 2000-12-19 | Atlantic Pharmaceuticals, Inc. | (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
-
1998
- 1998-02-03 PE PE1998000074A patent/PE71699A1/es not_active Application Discontinuation
- 1998-02-03 TW TW087101236A patent/TW522014B/zh not_active IP Right Cessation
- 1998-02-05 CO CO98005924A patent/CO4940445A1/es unknown
- 1998-02-05 AR ARP980100521A patent/AR011114A1/es not_active Application Discontinuation
- 1998-02-05 MY MYPI98000458A patent/MY136999A/en unknown
- 1998-02-06 KR KR1020067025791A patent/KR20060132053A/ko not_active Application Discontinuation
- 1998-02-06 CZ CZ991194A patent/CZ119499A3/cs unknown
- 1998-02-06 KR KR1020067011519A patent/KR20060076330A/ko active Search and Examination
- 1998-02-06 BR BR9806157-7A patent/BR9806157A/pt not_active Application Discontinuation
- 1998-02-06 AU AU62719/98A patent/AU6271998A/en not_active Abandoned
- 1998-02-06 EP EP98904980A patent/EP0969836B1/en not_active Revoked
- 1998-02-06 ES ES98904980T patent/ES2271986T3/es not_active Expired - Lifetime
- 1998-02-06 CN CN98802313XA patent/CN1132579C/zh not_active Expired - Fee Related
- 1998-02-06 JP JP53491998A patent/JP2001511184A/ja active Pending
- 1998-02-06 CA CA002267136A patent/CA2267136C/en not_active Expired - Fee Related
- 1998-02-06 NZ NZ335041A patent/NZ335041A/xx not_active IP Right Cessation
- 1998-02-06 HU HU0001527A patent/HUP0001527A3/hu unknown
- 1998-02-06 AT AT98904980T patent/ATE345133T1/de not_active IP Right Cessation
- 1998-02-06 KR KR1020077028293A patent/KR20080003012A/ko not_active Application Discontinuation
- 1998-02-06 WO PCT/US1998/002328 patent/WO1998034614A1/en active Application Filing
- 1998-02-06 RU RU99107283/14A patent/RU2209627C2/ru not_active IP Right Cessation
- 1998-02-06 SK SK472-99A patent/SK286035B6/sk not_active IP Right Cessation
- 1998-02-06 ZA ZA98977A patent/ZA98977B/xx unknown
- 1998-02-06 PL PL334232A patent/PL192075B1/pl unknown
- 1998-02-06 PT PT98904980T patent/PT969836E/pt unknown
- 1998-02-06 KR KR1019997003990A patent/KR100624259B1/ko not_active IP Right Cessation
- 1998-02-06 EP EP05108474A patent/EP1614421A3/en not_active Withdrawn
- 1998-02-06 DK DK98904980T patent/DK0969836T3/da active
- 1998-02-06 KR KR1020077015138A patent/KR20070086880A/ko not_active Application Discontinuation
- 1998-02-06 DE DE69836424T patent/DE69836424T2/de not_active Revoked
- 1998-06-02 UA UA99042037A patent/UA70290C2/uk unknown
-
1999
- 1999-05-04 NO NO19992157A patent/NO325611B1/no not_active IP Right Cessation
-
2000
- 2000-06-20 HK HK00103704A patent/HK1024187A1/xx not_active IP Right Cessation
-
2002
- 2002-02-25 US US10/082,685 patent/US20020123504A1/en not_active Abandoned
-
2005
- 2005-12-02 US US11/292,695 patent/US20060079489A1/en not_active Abandoned
-
2007
- 2007-11-14 NO NO20075846A patent/NO20075846L/no not_active Application Discontinuation
-
2008
- 2008-01-14 AR ARP080100161A patent/AR064895A2/es unknown
- 2008-01-14 AR ARP080100162A patent/AR064896A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR064895A2 (es) | Composicion farmaceutica anhidra para el tratamiento de desordenes inducidos por histamina | |
AR033796A1 (es) | Composicion farmaceutica | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
ES2194536T3 (es) | Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos. | |
CU23226B7 (es) | COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS | |
UY25242A1 (es) | Inhibidores de benzotiazol de la proteína tirosina cinasa | |
CO5160329A1 (es) | Metodo para proveer absorcion incrementada de una amina far- maceuticamente aceptable en la sangre de un humano y composi cion que comprende una amina farmaceuticamente un farmaco antiinflamatorio no esteroidal | |
NO20053106D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse. | |
ES2193337T3 (es) | Utilizacion de sales de estroncio para el tratamiento de la artrosis. | |
MX9203278A (es) | Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina. | |
NZ235877A (en) | Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence | |
AR012376A1 (es) | Formulacion de gel para la aplicacion topica | |
LV10050A (lv) | Farmaceitiska kompozicija ar zemam orala antikoagulanta un trombocitu inhibitora devam | |
BR9407720A (pt) | Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
ES2192234T3 (es) | Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. | |
BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
GT199900015A (es) | Procedimiento para tratar la insuficiencia cardiaca | |
DK0710108T3 (da) | Flydende, farmaceutisk præparat til oral anvendelse indeholdende 2-(4-isobutylphenyl)-propionsyre | |
PE20001325A1 (es) | Combinacion de cerivastatina y fibratos | |
ITMI930582A0 (it) | Composizione farmeceutiche ad attivita' analgesica | |
ES2191942T3 (es) | Nueva utilizacion de un antagonista especifico de los receptores 5ht2a. | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
CO5150193A1 (es) | DIHIDROXIACIDO ABIERTO Y SALES DE INHIBIDORES DE LA HMG-CoA REDUCTASA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |